Last reviewed · How we verify
Pentosan Polysulfate Sodium once weekly — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Pentosan Polysulfate Sodium once weekly (Pentosan Polysulfate Sodium once weekly) — Paradigm Biopharmaceuticals USA (INC).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pentosan Polysulfate Sodium once weekly TARGET | Pentosan Polysulfate Sodium once weekly | Paradigm Biopharmaceuticals USA (INC) | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pentosan Polysulfate Sodium once weekly CI watch — RSS
- Pentosan Polysulfate Sodium once weekly CI watch — Atom
- Pentosan Polysulfate Sodium once weekly CI watch — JSON
- Pentosan Polysulfate Sodium once weekly alone — RSS
Cite this brief
Drug Landscape (2026). Pentosan Polysulfate Sodium once weekly — Competitive Intelligence Brief. https://druglandscape.com/ci/pentosan-polysulfate-sodium-once-weekly. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab